Porntip Pinlaor Selected Research

Dimethylnitrosamine (Nitrosodimethylamine)

8/2021	CagA+ Helicobacter pylori infection and N-nitrosodimethylamine administration induce cholangiocarcinoma development in hamsters.
2/2018	Melatonin suppresses eosinophils and Th17 cells in hamsters treated with a combination of human liver fluke infection and a chemical carcinogen.
3/2016	Upregulation of 14-3-3 eta in chronic liver fluke infection is a potential diagnostic marker of cholangiocarcinoma.
2/2014	Increase of exostosin 1 in plasma as a potential biomarker for opisthorchiasis-associated cholangiocarcinoma.
10/2013	Melatonin inhibits cholangiocarcinoma and reduces liver injury in Opisthorchis viverrini-infected and N-nitrosodimethylamine-treated hamsters.
4/2013	Annexin A1: A new immunohistological marker of cholangiocarcinoma.
1/2012	Proteomic analysis to identify plasma orosomucoid 2 and kinesin 18A as potential biomarkers of cholangiocarcinoma.
7/2011	Curcumin decreases cholangiocarcinogenesis in hamsters by suppressing inflammation-mediated molecular events related to multistep carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Porntip Pinlaor Research Topics

Disease

24	Infections 04/2024 - 08/2009
23	Cholangiocarcinoma 05/2024 - 09/2006
16	Neoplasms (Cancer) 04/2024 - 09/2006
14	Opisthorchiasis 05/2024 - 08/2009
11	Inflammation (Inflammations) 08/2021 - 09/2006
10	Fibrosis (Cirrhosis) 01/2021 - 08/2009
5	Body Weight (Weight, Body) 01/2021 - 10/2010
5	Carcinogenesis 01/2017 - 06/2007
3	Digestive System Diseases 01/2017 - 03/2012
2	Strongyloidiasis 04/2024 - 01/2023
2	Chronic Renal Insufficiency 09/2023 - 01/2023
2	Persistent Infection 01/2023 - 01/2021
2	Dysbiosis 01/2023 - 01/2020
2	Parasitic Diseases (Parasitic Disease) 01/2022 - 01/2021
2	Cholangitis 01/2017 - 01/2014
1	Disease Progression 09/2023
1	Kidney Calculi (Kidney Stone) 02/2022
1	Urinary Tract Infections (Urinary Tract Infection) 02/2022
1	Dyslipidemias (Dyslipidemia) 01/2022
1	Fatty Liver 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Non-alcoholic Fatty Liver Disease 11/2019
1	Insulin Resistance 11/2019
1	Fascioliasis 01/2019
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2018

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 01/2021 - 06/2007
8	Dimethylnitrosamine (Nitrosodimethylamine)IBA 08/2021 - 07/2011
7	CurcuminIBA 01/2021 - 10/2009
6	EnzymesIBA 01/2023 - 12/2010
6	Praziquantel (Biltricide)FDA Link 01/2016 - 09/2006
5	CarcinogensIBA 08/2021 - 09/2006
5	Biomarkers (Surrogate Marker)IBA 04/2018 - 01/2012
4	Matrix Metalloproteinases (MMPs)IBA 08/2012 - 08/2009
3	Ivermectin (Mectizan)FDA Link 04/2024 - 09/2019
3	FructoseIBA 01/2022 - 11/2019
3	8-Hydroxy-2'-DeoxyguanosineIBA 08/2021 - 12/2010
3	ImmunosorbentsIBA 01/2019 - 01/2017
3	Immunoglobulin G (IgG)IBA 01/2019 - 03/2012
3	AntigensIBA 04/2018 - 03/2012
3	MelatoninIBA 02/2018 - 10/2010
3	CytokinesIBA 01/2018 - 07/2010
3	Hydroxyproline (4 Hydroxyproline)IBA 08/2012 - 08/2009
2	ProteomeIBA 09/2023 - 01/2023
2	Amino Acids FDA Link 09/2023 - 01/2021
2	Volatile Fatty AcidsIBA 01/2023 - 01/2022
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2021 - 01/2018
2	CholesterolIBA 01/2021 - 04/2013
2	LipidsIBA 11/2019 - 04/2013
2	Gemcitabine FDA Link 09/2019 - 05/2018
2	Anthocyanins (Anthocyanin)IBA 05/2018 - 12/2014
2	Orosomucoid (Seromucoid)IBA 01/2017 - 01/2012
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2017 - 08/2009
2	Messenger RNA (mRNA)IBA 12/2014 - 07/2010
2	CollagenIBA 08/2012 - 07/2010
2	Cyclin D1IBA 09/2011 - 07/2011
1	cyanoginosin LR (microcystin LR)IBA 05/2024
1	CateninsIBA 05/2024
1	Antineoplastic Agents (Antineoplastics)IBA 04/2024
1	Protein Kinases (Protein Kinase)IBA 12/2023
1	MicroRNAs (MicroRNA)IBA 12/2023
1	Bacterial Proteins (Bacterial Protein)IBA 09/2023
1	MucinsIBA 01/2023
1	UreaseIBA 02/2022
1	StruviteIBA 02/2022
1	hydroxide ionIBA 01/2022
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2022
1	HMGB1 Protein (HMG1)IBA 08/2021
1	Interleukin-8 (Interleukin 8)IBA 08/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	muricholic acidIBA 01/2021
1	GlobulinsIBA 01/2021
1	MutagensIBA 01/2021
1	FumaratesIBA 01/2021
1	phenylacetylglycineIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Ethyl MethanesulfonateIBA 01/2021
1	Tricarboxylic AcidsIBA 01/2021
1	malic acid (malate)IBA 01/2021
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2021
1	GlycopeptidesIBA 01/2021
1	Sodium Glutamate (Accent)IBA 01/2020
1	4-cresol sulfateIBA 01/2020
1	Antiparasitic Agents (Antiparasitics)IBA 09/2019
1	Cysteine Proteases (Cysteine Protease)IBA 01/2019
1	Triose-Phosphate Isomerase (Triosephosphate Isomerase)IBA 04/2018
1	Calcium-Binding ProteinsIBA 04/2018
1	Neuropilin-1IBA 04/2018
1	Aldo-Keto ReductasesIBA 04/2018
1	CarbohydratesIBA 04/2018
1	S100 Calcium Binding Protein A6IBA 04/2018
1	Insulin ReceptorIBA 01/2018
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2018
1	Streptozocin (Streptozotocin)FDA Link 01/2018
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 05/2018 - 01/2018
2	Oral Administration 12/2014 - 10/2010
1	Therapeutics 04/2024
1	Chemoprevention 01/2018